Latest Breaking News On - First in class dual - Page 1 : comparemela.com

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pawel przewiezlikowskiHendrik nogaiPartner menarini groupMenarini groupEuropean hematology associationWarsaw stock exchangeAnnual european hematology associationChief medical officerDose escalation studyEfficacy data updateClinical signsMutation positiveFirst in class dualMutated acute myeloid leukemiaRyvu therapeutics

Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association Congress Partner Menarini Group to present clinical poster on SEL24 (MEN1703)

/PRNewswire/ Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address.

Hendrik nogaiMenarini groupEuropean hematology associationWarsaw stock exchangeOngoing phaseDose escalation studyAnnual european hematology associationChief medical officerClinical signsMutation positiveDerived cellsEfficacy dataFirst in class dualMutated acute myeloid leukemiaRyvu therapeutics